Abstract
Adult tissues were discovered to possess resident stem cell populations and were termed as mesenchymal stem cells (MSCs). These stem cells are considered to be the best alternatives to overcome certain limitations associated with embryonic stem cells. Epithelial cells of amnion were reported to exhibit characteristic features of stem cells and neural cells. This led to speculation of using them for treating various pathological conditions including spinal cord injury (SCI). Studies conducted elsewhere and our laboratory found beneficial aspects of amniotic epithelial cell (AEC) transplantation for certain neurological conditions. Studies on the usefulness of these cells in SCI appear to be limited. In our lab, we have observed beneficial effects of human amniotic epithelial cells (hAECs) when transplanted in contusive SCI model in rats. This study was found to be unique as there was no other study in which these cells were tested for contusive SCI repair. In our experience, these cells may not possess the two important criteria to be qualified for stem cells viz. self-renewal and multilineage differentiation capacity. Notwithstanding to be qualified for the stem cell tag, amniotic epithelial cells may have the potentials for contusive SCI repair.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- AEC:
-
Amniotic epithelial cells
- CNS:
-
Central nervous system
- EGF:
-
Epidermal growth factor
- FGF-2:
-
Fibroblast growth factor
- hAEC:
-
Human amniotic epithelial cells
- MSC:
-
Mesenchymal stem cells
- SCI:
-
Spinal cord injury/spinal cord injured
References
Varma AK, Das A, Wallace G, Barry J, Vertegel AA, Ray SK, Banik NL. Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers. Neurochem Res. 2013;38:895–905.
Young W, Constantini S. The effects of methylprednisolone and ganglioside GM1 on acute spinal cord injury in rats. J Neurosurg. 1994;80:97–111.
Tebet MA, Filho TEP, Machado IR, Carvalho MOP, Hanania FR, Dac K. Effect of methylprednisolone in medullar injury in rats: a functional and histological analysis. Acta Ortop Bras. 2003;11:80–7.
Arias MJ. Effect of naloxone on functional recovery after experimental spinal cord injury in the rat. Surg Neurol. 1985;23:440–2.
Wang X, Budel S, Baughman K, Gould G, Song KH, Strittmatter SM. Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth. J Neurotrauma. 2009;26:81–95.
Dietrich WD, Levi AD, Wang M, Green BA. Hypothermic treatment for acute spinal cord injury. Neurotherapeutics. 2011;8:229–39.
Asamoto S, Sugiyama H, Doi H, Iida M, Nagao T, Matsumoto K. Hyperbaric oxygen (HBO) therapy for acute traumatic cervical spinal cord injury. Spinal Cord. 2000;38:538–40.
Goldsmith HS, Duckett S, Chen WF. Spinal cord vascularisation by intact omentum. Am J Surg. 1975;129:262–5.
Vrbova G, Clowry G, Nogradi A, Sieradzan K. Transplantation of neural tissue into the spinal cord. Austin: R.G. Landes Company; 1994. p. 51–125.
Wang M, Zhai P, Chen X, Schreyer DJ, Sun X, Cui F. Bioengineered scaffolds for spinal cord repair. Tissue Eng Part B Rev. 2011;17:177–94.
Rivlin AS, Tator CH. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg. 1977;47:577–81.
Benes Jr V, Rokyta R. Experimental spinal cord injury: lumbar vertebra resection to shorten the gap between spinal cord stumps. Acta Neurochir (Wien). 1988;90:152–6.
Jeong MA, Plunet W, Streijger F, Lee JH, Plemel JR, Park S, Lam CK, Liu J, Tetzlaff W. Intermittent fasting improves functional recovery after rat thoracic contusion spinal cord injury. J Neurotrauma. 2011;28:479–92.
Liebscher T, Schnell L, Schnell D, Scholl J, Schneider R, Gullo M, Fouad K, Mir A, Rausch M, Kindler D, Hamers FP, Schwab ME. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol. 2005;58:706–19.
Merkler D, Metz GAS, Raineteau O, Dietz V, Schwab ME, Fouad K. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci. 2001;21:3665–73.
Poulsen DJ, Harrop JS, During MJ. Gene therapy for spinal cord injury and disease. J Spinal Cord Med. 2002;25:2–9.
McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, Gottlieb DI, Choi DW. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med. 1999;5:1410–2.
Mothe AJ, Tator CH. Advances in stem cell therapy for spinal cord injury. J Clin Invest. 2012;122:3824–34.
Parolini O, Alviano F, Bagnara GP, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells. 2008;26:300–11.
Saporta S, Kim JJ, Willing AE, Fu ES, Davis CD, Sanberg PR. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J Hematother Stem Cell Res. 2003;12:271–8.
Lin WP, Chen XW, Zhang LQ, Wu CY, Huang ZD, Lin JH. Effect of neuroglobin genetically modified bone marrow mesenchymal stem cells transplantation on spinal cord injury in rabbits. PLoS One. 2013;8:e63444. doi:10.1371/journal.pone.0063444.
Bauchet L, Lonjon N, Perrin FE, Gilbert C, Privat A, Fattal C. Strategies for spinal cord repair after injury: a review of the literature and information. Ann Phys Rehabil Med. 2009;52:330–51.
Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, Dumont A. Acute spinal cord injury. Part I: pathophysiologic mechanisms. Clin Neuropharmacol. 2001;24:254–64.
Bretzner F, Liu J, Currie E, Roskams AJ, Tetzlaff W. Undesired effects of a combinatorial treatment for spinal cord injury—transplantation of olfactory ensheathing cells and BDNF infusion to the red nucleus. Eur J Neurosci. 2008;28:1795–807.
Maier IC, Ichiyama RM, Courtine G, Schnell L, Lavrov I, Edgerton R, Schwab ME. Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury. Brain. 2009;132:1426–40.
Nakamura M, Okano H. Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells. Cell Res. 2013;23:70–80.
Coutts M, Keirstead HS. Stem cells for the treatment of spinal cord injury. Exp Neurol. 2008;209:368–77.
Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, Steward O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci. 2005;25:4694–705.
Carson CT, Aigner S, Gage FH. Stem cells: the good, bad and barely in control. Nat Med. 2006;12:1259–68.
Holm S. ‘New embryos’—new challenges for the ethics of stem cell research. Cells Tissues Organs. 2008;187(4):257–62.
Li JY, Christophersen NS, Hall V, Soulet D, Brundin P. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci. 2008;31(3):146–53.
Lavker RM, Sun TT. Epidermal stem cells: properties, markers, and location. Proc Natl Acad Sci U S A. 2000;97:13473–5.
Toma JG, Akhavan M, Fernandes KJL, Barnabe-Heider F, Sadikot A, Kaplan DR, Miller FD. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol. 2001;3:778–84.
Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61:364–70.
Mitchell KE, Weiss ML, Michell BM, Martin P, Davis D, Morales L, Helwig B, Beerenstrauch M, Aboueasa K, Hildreth T, Troyer D. Matrix cells from Wharton’s Jelly form neurons and glia. Stem Cells. 2003;21:50–60.
Coppil PD, Bartsch G, Siddiquil MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25:100–6.
Perry BC, Zhou D, Wu X, Yang FC, Byers MA, Chu TM, Hockema JJ, Woods EJ, Goebel WS. Collection, cryopreservation, and characterization of human dental pulp-derived mesenchymal stem cells for banking and clinical use. Tissue Eng Part C Methods. 2008;14:149–56.
Vawda R, Fehlings MG. Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives. Curr Stem Cell Res Ther. 2013;8:25–38.
Yoshihara H, Shumsky JS, Neuhuber B, Otsuka T, Fischer I, Murray M. Combining motor training with transplantation of rat bone marrow stromal cells does not improve repair or recovery in rats with thoracic contusion injuries. Brain Res. 2006;1119:65–75.
Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood. 2006;108:2114–20.
In ‘t Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, Kanhaia HH. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338–45.
Zhao P, Ise H, Hongo M, Ota M, Konishi I, Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation. 2005;79:528–35.
Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109:235–42.
Sakuragawa N, Thangavel R, Mizuguchi M, Hirasawa M, Kamo I. Expression of markers for both neuronal and glial cells in human amniotic epithelial cells. Neurosci Lett. 1996;209:9–12.
Miki T, Lehmann T, Cai H, Stolz DB, Strom SC. Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005;23:1549–59.
Sankar V, Tamilselvi P, Prem Kumar J, Sridharan N, Sridhar Skylab R, Vijaya Prakash KM. Novel neurotrophic factor secreted by amniotic epithelial cells. Biocell. 2009;33:81–9.
Olfert ED, Cross BM, McWilliam AA. Guide to the care and use of experimental animals, vol. 1. 2nd ed. Ottawa: Canadian Council on Animal Care; 1993.
Vallachira A. Veterinarian’s drug index. New Delhi: Jaypee Brothers Medical Publishers Ltd.; 1985. p. 172–4.
Levine JD, Gordon NC, Taiwo YO, Coderre TJ. Potentiation of pentazocine analgesia by low-dose naloxone. J Clin Invest. 1988;82:1574–7.
Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12:1–21.
Culling CFA. Handbook of histopathological and histochemical techniques. 3rd ed. London: Butterworths; 1972.
Elias H, Hyde H. An elementary introduction to stereology. Am J Anat. 1980;159:411–46.
Sakuragawa N, Misawa H, Ohsugi K, Kakishita K, Ishii T, Thangavel R, Tohyama J, Elwan M, Yokoyama Y, Okuda O, Arai H, Ogino I, Sato K. Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease. Neurosci Lett. 1997;232:53–6.
Elwan MA, Sakuragawa N. Evidence for synthesis and release of catecholamines by human amniotic epithelial cells. Neuroreport. 1997;8:3435–8.
Bankiewicz KS, Palmatier M, Plunkett RJ, Cummins A, Oldfield EH. Reversal of hemiparkinsonian syndrome in nonhuman primates by amnion implantation into caudate nucleus. J Neurosurg. 1994;81:869–76.
Kakishita K, Elwan MA, Nakao N, Itakura T, Sakuragawa N. Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson’s disease: a potential source of donor for transplantation therapy. Exp Neurol. 2000;165:27–34.
Kakishita K, Nakao N, Sakuragawa N, Itakura T. Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Res. 2003;980:48–56.
Okawa H, Okuda O, Arai H, Sakuragawa N, Sato K. Amniotic epithelial cells transform into neuron-like cells in the ischemic brain. Neuroreport. 2001;12:4003–7.
Sankar V, Muthusamy R. Role of amniotic epithelial cell transplantation in spinal cord injury repair research. Neuroscience. 2003;118:11–7.
Zhi-yuan W, Guo-zhen H, Yi L, Xin W, Li-he G. Transplantation of human amniotic epithelial cells improves hindlimb function in rats with spinal cord injury. Chin Med J (Engl). 2006;119:2101–7.
Meng XT, Li C, Dong ZY, Liu JM, Li W, Liu Y, Xue H, Chen D. Co-transplantation of bFGF-expressing amniotic epithelial cells and neural stem cells promotes functional recovery in spinal cord-injured rats. Cell Biol Int. 2008;32:1546–58.
Xue H, Zhang XY, Liu JM, Song Y, Li YF, Chen D. Development of a chemically extracted acellular muscle scaffold seeded with amniotic epithelial cells to promote spinal cord repair. J Biomed Mater Res A. 2013;101:145–56.
Hasegawa K, Chang YW, Li H, Berlin Y, Ikeda O, Goldsmith NK, Grumet M. Embryonic radial glia bridge spinal cord lesions and promote functional recovery following spinal cord injury. Exp Neurol. 2004;193:394–410.
McEwen ML, Springer JE. Quantification of locomotor recovery following spinal cord contusion in adult rats. J Neurotrauma. 2006;23:1632–53.
Ma J, Novikov LN, Wiber M, Kellerth JO. Delayed loss of spinal motoneurons after peripheral nerve injury in adult rats: a quantitative morphological study. Exp Brain Res. 2001;139:216–23.
Rabchevsky AG, Fugaccia I, Sullivan PG, Scheff SW. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J Neurotrauma. 2001;18:513–22.
Kalayci M, Coskun O, Cagavi F, Kanter M, Armutcu F, Gul S, Acikgoz B. Neuroprotective effects of ebselen on experimental spinal cord injury in rats. Neurochem Res. 2005;30:403–10.
Corti S, Locatelli F, Papadimitriou D, Bo RD, Nizzardo M, Nardini M, Donadoni C, Salani S, Fortunato F, Strazzer S, Bresolin N, Comi GP. Neural stem cells LewisX1CXCR41 modify disease progression in an amyotrophic lateral sclerosis model. Brain. 2007;130:1289–305.
Duggal N, Lach B. Selective vulnerability of the lumbosacral spinal cord after cardiac arrest and hypotension. Stroke. 2002;33:116–21.
Uchida S, Inanaga Y, Kobayashi M, Hurukawa S, Araie M, Sakuragawa N. Neurotrophic function of conditioned medium from human amniotic epithelial cells. J Neurosci Res. 2000;62:585–90.
Uchida S, Suzuki Y, Araie M, Kashiwagi K, Otori Y, Sakuragawa N. Factors secreted by human amniotic epithelial cells promote the survival of rat retinal ganglion cells. Neurosci Lett. 2003;341:1–4.
Sakuragawa N, Elwan MA, Uchida S, Fujii T, Kawashima K. Non-neuronal neurotransmitters and neurotrophic factors in amniotic epithelial cells: expression and function in humans and monkey. Jpn J Pharmacol. 2001;85:20–3.
Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000;20:173–7.
Weiner LP. Neural stem cells—methods and protocols. 2nd ed. Totova: Humana Press; 2008. p. 1–134.
Pratama G, Vaghjiani V, Tee JY, Liu YH, Chan J, Tan C, Murthi P, Gargett C, Manuelpillai U. Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications. PLoS One. 2011;6:e26136.
Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, Plemel JR, Plunet WT, Tsai EC, Baptiste D, Smithson LJ, Kawaja MD, Fehlings MG, Kwon BK. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma. 2011;28:1611–82.
Acknowledgement
Part of the findings were presented in the First International Workshop on Placenta-derived Stem cells conducted at Brescia, Italy during 23rd to 25th March 2007 proceedings of which were published [19]. This study was supported by UGC-UWPFE research grant and research starter fund from University of Madras to Sankar Venkatachalam. This study formed a part of PhD thesis submitted by Prem Kumar Jayapal to University of Madras.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jayapal, P.K., Neelamegan, S., Palaniappan, T., Rajan, S.S., Krishnan Muthaiah, V.P., Venkatachalam, S. (2014). Human Amniotic Epithelial Cells Transplantation for Contusive Spinal Cord Injury Repair. In: Atala, A., Murphy, S. (eds) Perinatal Stem Cells. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1118-9_22
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1118-9_22
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1117-2
Online ISBN: 978-1-4939-1118-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)